Bioquímica y Biología Molecular
Departamento
Imperial College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Imperial College London (57)
2024
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
Allergy: European Journal of Allergy and Clinical Immunology
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 11, pp. 2851-2874
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
Pediatric Allergy and Immunology, Vol. 34, Núm. 1
-
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203
-
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients
Experimental Dermatology, Vol. 32, Núm. 10, pp. 1785-1793
2022
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2313-2336
-
Ca2+ imaging of self and other in medial prefrontal cortex during social dominance interactions in a tube test
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 31
-
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms
Neurobiology of Disease, Vol. 163
2021
-
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
Clinical and Translational Allergy, Vol. 11, Núm. 4
-
COVID-19 pandemic and allergen immunotherapy—an EAACI survey
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 11, pp. 3504-3516
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 6, pp. 1629-1639
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 90-113
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964
-
Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate
Frontiers in Immunology, Vol. 12
-
Surfactant protein b promotes cytosolic sirna delivery by adopting a virus-like mechanism of action
ACS Nano, Vol. 15, Núm. 5, pp. 8095-8109
-
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 6, pp. 1640-1660